Latest News

 Filter by Provider

Sales growth is only part of the story for one of the leading AI labs, which is expected to go public this year.

You can't go wrong with either, but one seems to have more runway.

Kits Eyecare (TSE:KITS) is targeting further growth in the online optical market by expanding its higher-margin glasses business, increasing brand awareness through select physical locations and leveraging a manufacturing operation that management says has substantial unused capacity. Speaking at a

Has the AI boom already peaked?

Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept in IgA nephropathy and inaxaplin in APOL1-mediated kidney disease, or AMKD. Chief Executive Officer and President Reshm

SpaceX delivered a stronger quarter than I expected. But its accelerating AI spending leaves shareholders with a very expensive question.

Novartis (NYSE:NVS) presented Phase III results for remibrutinib in relapsing multiple sclerosis, reporting that the oral Bruton’s tyrosine kinase inhibitor reduced relapse rates and MRI lesion activity versus teriflunomide in the REMODEL-1 and REMODEL-2 studies. The company said global regulatory

Analyze the current issues impacting data centres, from AI investment strategies to concerns reminiscent of past financial crises.

Canadian utility stocks report soon. See what Fortis, Emera and Canadian Utilities investors should consider before buying ahead of earnings.

The hard drive maker's growth keeps speeding up. Has the stock's slide gone too far?

Explore the advantages of a TFSA and discover how selecting the ideal TFSA stock can maximize your investment returns.

Tourmaline's costs, market access, and planned dividend increase provide a more durable investment case than referendum relief.

Vinci Compass Investments (NASDAQ:VINP) said it plans to launch Vinci Permanent Capital Solutions, or VPCS, through the acquisition of AustralRe, a Latin American reinsurance platform that Vinci helped found in 2011. The transaction is expected to close in the first quarter of 2027, subject to regu

Crombie REIT offers a dependable yield and a low payout ratio. Discover why it’s a top choice for monthly retirement income.

SpaceX could be a bigger threat than investors expected.

One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.

Canadian bank stocks offer different buying cases in late 2026. Compare Scotiabank, TD and Royal Bank on income, earnings and execution risks.

While geopolitical uncertainties and commodity price volatility remain potential risks, Enbridge’s Q3 outlook remains strong.

Need $500 a month tax free? At a 6.9% yield, about $87,000 in a TFSA could do it. See how SmartCentres REIT and Automotive Properties REIT fit in the plan.

Here’s a 5% dividend stock that can generate $100 every month from a large portfolio of real estate properties spread across Canada.

Beware that re‑contributing withdrawn funds in the same calendar year can lead to a penalty from potential excess contribution.

TFSA users can prepare for year-end by checking contribution room, putting long-term cash to work and reviewing diversification with three ETFs.

A refund or bonus could bring your emergency fund months closer to completion and give your investments more time to grow.

First Phosphate (NASDAQ:PHOS) is advancing a proposed igneous phosphate mining project in northern Quebec, with a feasibility study targeted for the first quarter of 2027 and initial production envisioned by 2030, President Armand MacKenzie said during a company presentation. MacKenzie, who said he

Your TFSA contribution room can become a self-sustaining cash machine if invested in a high-yield stock paying monthly dividends.

Groupe Dynamite stock is down 38% from its high, yet sales and profits are surging. See why this almost 3.8% dividend yield may be worth a closer look now.

P&G delivered surprisingly strong results in its fiscal first quarter. Here's what it means for investors.

Competition in the neocloud space is heating up, and it could be a problem for CoreWeave.

The warehouse club's earnings might keep rising at a double-digit rate. Would that be enough to beat an index fund?

Loan portfolio surged past BRL 1.1 trillion as digital clients hit 45 million.

The Texas-based financial services conglomerate unveiled its third-quarter results.

Claiming Social Security at 62 locks in a permanent reduction that compounds over decades of retirement.

Net income surged 88% as net interest margin expanded and loan growth accelerated.

Musk recently added fuel to already rampant rumors about a future SpaceX-Tesla merger.

Apple is making a new push into smart homes, but will consumers pay premium prices for products they can already get elsewhere?

Demand for AI-powered customer engagement tools is surging.

The energy sector is volatile and changing, which is why you want to stick with industry leaders like Exxon, TotalEnergies, and Enterprise.

Bloomberg's report of SpaceX negotiations for 80,000 cell sites reignited carrier-competition fears, sending wireless stocks lower, today, Oct. 23, 2026.

Today, Oct. 23, 2026, analyst notes lifted a price target to $275 as the company's super-intelligence segment accelerates.

What does the $650 billion wave of private equity capital moving into Main Street mean for owners who are unprepared for acquisition?

Margin expansion offset by credit headwinds and revised loan growth guidance.

Leasing volume hit 815,000 square feet as occupancy climbed to 83%.

Today, Oct. 23, 2026, investors punished the fuel-cell maker after flagging negative operating cash flow and heavy expansion spending.

But AI investors can’t go wrong with either stock.

Perspective Therapeutics (NYSEAMERICAN:CATX) presented updated clinical data for its VMT-α-NET program at the European Society for Medical Oncology Congress 2026, reporting tumor responses, an 18-month progression-free survival landmark rate of 72% across three cohorts and no dose-limiting toxicitie

A qualifying RRSP can receive certain U.S. dividends without withholding, but Canadian-listed ETFs follow a different route.

The online brokerage could venture beyond options with single-stock perps.

This stock offers an attractive 6.8% dividend yield with monthly distributions, and is well-positioned to sustain its payouts.

Discover how to evaluate dividend stocks for dependable cash flow and reduce risks in a volatile economic environment.